These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 18715257)
1. Elevated frequency of p53 genetic mutations and AgNOR values in squamous cell carcinoma. Bukhari MH; Niazi S; Khaleel ME; Sharif MA; Ghani R; Mehmood MT; Tahseen M; Chaudhry NA; Hasan M J Cutan Pathol; 2009 Feb; 36(2):220-8. PubMed ID: 18715257 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of new immunohistochemistry scoring of p53 protein expression in cutaneous squamous cell carcinoma of mice. Bukhari MH; Niazi S; Anwar M; Chaudhry NA; Naeem S Ann N Y Acad Sci; 2008 Sep; 1138():1-9. PubMed ID: 18837875 [TBL] [Abstract][Full Text] [Related]
3. Relationship of immunohistochemistry scores of altered p53 protein expression in relation to patient's habits and histological grades and stages of squamous cell carcinoma. Bukhari MH; Niazi S; Chaudhry NA J Cutan Pathol; 2009 Mar; 36(3):342-9. PubMed ID: 19220630 [TBL] [Abstract][Full Text] [Related]
5. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120 [TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation. Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287 [TBL] [Abstract][Full Text] [Related]
7. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin. Sakiz D; Turkmenoglu TT; Kabukcuoglu F Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853 [TBL] [Abstract][Full Text] [Related]
8. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474 [TBL] [Abstract][Full Text] [Related]
9. Patches of mutant p53-immunoreactive epidermal cells induced by chronic UVB Irradiation harbor the same p53 mutations as squamous cell carcinomas in the skin of hairless SKH-1 mice. Kramata P; Lu YP; Lou YR; Singh RN; Kwon SM; Conney AH Cancer Res; 2005 May; 65(9):3577-85. PubMed ID: 15867351 [TBL] [Abstract][Full Text] [Related]
11. Molecular pathology in basal cell cancer with p53 as a genetic marker. Pontén F; Berg C; Ahmadian A; Ren ZP; Nistér M; Lundeberg J; Uhlén M; Pontén J Oncogene; 1997 Aug; 15(9):1059-67. PubMed ID: 9285560 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors. Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663 [TBL] [Abstract][Full Text] [Related]
13. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma. Ansarin H; Daliri M; Soltani-Arabshahi R Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476 [TBL] [Abstract][Full Text] [Related]
14. TP53 mutations in human skin cancers. Giglia-Mari G; Sarasin A Hum Mutat; 2003 Mar; 21(3):217-28. PubMed ID: 12619107 [TBL] [Abstract][Full Text] [Related]
15. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Bäckvall H; Asplund A; Gustafsson A; Sivertsson A; Lundeberg J; Ponten F Mutat Res; 2005 Apr; 571(1-2):65-79. PubMed ID: 15748639 [TBL] [Abstract][Full Text] [Related]
16. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma. Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292 [TBL] [Abstract][Full Text] [Related]
17. High numbers of human skin cancers express MMP2 and several integrin genes. Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742 [TBL] [Abstract][Full Text] [Related]
18. Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion. Barzilai A; Lyakhovitsky A; Trau H; Fogel M; Huszar M J Am Acad Dermatol; 2007 Oct; 57(4):669-76. PubMed ID: 17870432 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas. Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568 [TBL] [Abstract][Full Text] [Related]
20. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas. Koseoglu RD; Sezer E; Eyibilen A; Aladag I; Etikan I J Cutan Pathol; 2009 Sep; 36(9):958-65. PubMed ID: 19187116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]